A detailed history of Keebeck Alpha, LP transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Keebeck Alpha, LP holds 894 shares of MEDP stock, worth $277,703. This represents 0.2% of its overall portfolio holdings.

Number of Shares
894
Previous 582 53.61%
Holding current value
$277,703
Previous $239,000 24.69%
% of portfolio
0.2%
Previous 0.18%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$320.58 - $457.29 $100,020 - $142,674
312 Added 53.61%
894 $298,000
Q2 2024

Aug 12, 2024

BUY
$372.0 - $424.34 $14,508 - $16,549
39 Added 7.18%
582 $239,000
Q1 2024

May 13, 2024

BUY
$284.87 - $413.31 $154,684 - $224,427
543 New
543 $219,000
Q3 2023

Nov 02, 2023

SELL
$233.98 - $281.67 $6,083 - $7,323
-26 Reduced 1.77%
1,441 $348,000
Q2 2023

Jul 25, 2023

BUY
$187.26 - $240.17 $274,710 - $352,329
1,467 New
1,467 $352,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $9.66B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Keebeck Alpha, LP Portfolio

Follow Keebeck Alpha, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keebeck Alpha, LP, based on Form 13F filings with the SEC.

News

Stay updated on Keebeck Alpha, LP with notifications on news.